RPL5P7

Across TCGA pan-cancer cohorts, RPL5P7 RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of RPL5P7’s most consistent transcriptional readouts.

The strongest signal is observed in stomach adenocarcinoma (STAD), where RPL5P7 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RPL5P7 is over-expressed in tumor.

STAD, LUSC, and LUAD are the cancer types where RPL5P7 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RPL5P7 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
STAD	Male	All	+0.067	.010	4	view →
LUSC	All	All	+0.030	.001	2	view →
LUAD	All	All	+0.027	.049	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

RPL5P7–STAD

Open the STAD breakdown →